Of all the diagnoses a couple can receive at the end of a fertility investigation, unexplained infertility may be the most psychologically complex. It is not reassuring — because it means the problem that is preventing pregnancy has not been identified. It is not actionable in the straightforward way that a specific diagnosis is — because there is no identifiable condition to treat. And it comes with an implicit message that, for many couples, is the most difficult part of the whole experience: we have done our standard tests, and we cannot tell you why this is not happening.

Unexplained infertility is defined as the failure of a couple to conceive after twelve months of regular unprotected intercourse, in the absence of any identifiable cause found on standard fertility investigation — normal ovarian reserve, normal hormones, normal uterine assessment on imaging, at least one patent fallopian tube, and a semen analysis within normal reference ranges.

In clinical practice, unexplained infertility accounts for approximately 25 to 30 percent of all infertility diagnoses — making it one of the most common diagnostic categories in fertility medicine.

But here is the clinical reality that this article is written to communicate: unexplained infertility is not a true diagnosis. It is a placeholder — a label for the gap between what the standard investigation found and what a more thorough investigation might reveal. And in a substantial proportion of couples labeled as unexplained, the underlying cause is not truly absent. It was simply not found by the investigation that was performed.

The Limits of the Standard Investigation

To understand why unexplained infertility is so often not truly unexplained, it helps to understand precisely what the standard fertility investigation does and does not assess.

The standard investigation typically includes a day-two to three hormonal profile — FSH, LH, and estradiol — to assess ovarian reserve and ovulatory function. It includes an AMH measurement. It includes a transvaginal ultrasound to count antral follicles, assess the ovaries, and examine the uterus. It includes a hysterosalpingography (HSG) or sonosalpingography to assess tubal patency. And it includes a standard semen analysis measuring count, motility, and morphology.

These investigations are reasonable starting points. They identify many common causes of infertility — anovulation, severely diminished reserve, bilateral tubal blockage, severe male factor. But they leave significant dimensions of both partners' fertility entirely unassessed.

What the standard investigation misses in the male partner:

The standard semen analysis does not measure sperm DNA fragmentation. A man with a completely normal count, motility, and morphology can have a severely elevated DNA Fragmentation Index (DFI) — damaged genetic material within the sperm that compromises embryo developmental competence and implantation rates. This is the most commonly missed male factor, and it is absent from the standard investigation entirely. High sperm DNA fragmentation cannot be diagnosed from a standard semen analysis. It requires a specific, separate test — and in couples with unexplained infertility where this test has not been performed, the male factor has not been adequately assessed.

What the standard investigation misses in the female partner:

The uterine cavity assessment by HSG or ultrasound is frequently incomplete. HSG provides information about tubal patency and gross uterine shape but does not reliably identify small intrauterine abnormalities — polyps, small submucosal fibroids, mild intrauterine adhesions — that can impair implantation. Only hysteroscopy — direct visualization of the uterine cavity — reliably excludes or identifies these conditions.

The implantation window is not assessed. Standard practice assumes that the endometrial receptivity window — the period during which the endometrium is capable of accepting an embryo — opens at a standard time relative to ovulation or progesterone exposure. In a proportion of women, this window is displaced — opening earlier or later than assumed. This displacement cannot be detected by ultrasound, hormonal testing, or any component of the standard investigation. It requires ERA testing — endometrial receptivity analysis — a specific endometrial biopsy assessed for gene expression patterns indicating receptive versus non-receptive endometrium.

Immunological factors are not assessed. Antiphospholipid syndrome, thyroid antibodies, natural killer cell abnormalities, and thrombophilic conditions that can impair implantation and early pregnancy maintenance are entirely absent from the standard fertility work-up at most clinics.

Chronic endometritis is not assessed. This low-grade inflammatory condition of the endometrial lining — present in approximately 30 percent of women with unexplained infertility in some studies — is silent, produces no symptoms, is not visible on ultrasound, and is diagnosed only by endometrial biopsy. It is an entirely treatable cause of implantation failure that the standard investigation systematically misses.

The cumulative picture is clear: a couple labeled as having unexplained infertility based on standard investigations has had a work-up that misses sperm DNA fragmentation, uterine cavity abnormalities, endometrial receptivity displacement, immunological factors, and chronic endometritis — all of which are real, diagnosable, and in most cases treatable causes of infertility.

What "Unexplained" Often Actually Means

In clinical practice, when a comprehensive investigation — one that goes beyond the standard work-up to include sperm DNA fragmentation testing, hysteroscopy, ERA, immunological panel, and endometrial biopsy — is performed in couples previously labeled as unexplained, specific findings are identified in a substantial proportion.

The most commonly found factors in couples with previously unexplained infertility, when the investigation is extended to include these assessments, are:

Elevated sperm DNA fragmentation — found in a proportion of male partners whose standard semen analysis was reported as entirely normal. Often the finding that explains why the couple can conceive (fertilization occurs) but cannot sustain early pregnancy (DNA-damaged embryos arrest before implantation).

Intrauterine structural abnormalities — polyps, small fibroids, or mild adhesions found on hysteroscopy in women whose standard ultrasound and HSG were reported as normal. Present, silent, and impairing implantation.

Displaced implantation window — identified by ERA testing in a proportion of women who had normal endometrial thickness and pattern but were transferring embryos consistently outside their receptive phase.

Chronic endometritis — found on endometrial biopsy in a significant minority of unexplained infertility cases. Entirely undetectable by any other investigation. Entirely treatable with targeted antibiotics.

Immunological conditions — particularly thyroid autoimmunity and antiphospholipid antibodies — identified in investigations that the standard work-up does not include.

These findings are not exotic or unlikely. They are specific, common, and routinely missed by the standard investigation. And for every couple in whom these findings are identified and treated, the label "unexplained" is replaced by a specific diagnosis — and a specific treatment pathway.

This is the most important clinical message about unexplained infertility: for a substantial proportion of the couples who carry this label, the infertility is explained. It is explained by a factor that the standard investigation was not designed to find. The explanation becomes available when the investigation is thorough enough to look for it.

True Unexplained Infertility — When the Investigation Is Complete

It would be dishonest to suggest that every couple labeled as unexplained has a findable cause. After the most thorough possible investigation — sperm DNA fragmentation, hysteroscopy, ERA, immunological panel, endometrial biopsy — a proportion of couples will still have no identifiable cause for their infertility.

In these couples, the infertility may reflect mechanisms that are not yet measurable with current technology. Subtle defects in egg-sperm interaction. Very mild endometrial dysfunction not captured by current ERA methodology. Micro-environmental factors in the follicular or uterine milieu that affect developmental competence at a molecular level below current diagnostic resolution.

For these couples — in whom a complete investigation has genuinely not revealed a cause — the label unexplained infertility is clinically accurate. And the management shifts from cause-directed treatment to empirical treatment — treatment that improves the overall probability of conception without targeting a specific identified cause.

Treatment Options for Unexplained Infertility

The treatment approach for unexplained infertility depends on whether the investigation has been truly complete — and on the couple's age, the duration of infertility, and the extent to which the complete investigation has been performed.

When the investigation is incomplete — investigate first. For couples in whom the standard investigation has not included sperm DNA fragmentation testing, hysteroscopy, ERA, or endometrial biopsy, the first treatment recommendation at Metro IVF is always to complete the investigation. The probability that one of the assessments described above will find a specific, treatable cause is sufficiently high that proceeding with empirical treatment before completing the investigation means treating a potentially identifiable problem blindly — with lower probability of success than cause-directed treatment would achieve.

Ovulation optimization and timed intercourse or IUI — for younger couples with incomplete investigation or early-stage unexplained infertility. For couples where the woman is under 35, the infertility duration is less than two years, and the investigation is otherwise normal, a period of timed intercourse with ovulation monitoring — or IUI for one to three cycles — is a reasonable initial empirical approach while any additional investigation is being conducted. The rationale is that unexplained infertility in young couples may simply represent the natural variability of conception timing — a temporary misalignment of ovulation and sperm delivery — that improved timing addresses. IUI success rates in unexplained infertility for younger patients are approximately 10 to 15 percent per cycle.

IVF — the most important empirical treatment for unexplained infertility. IVF plays a uniquely diagnostic as well as therapeutic role in unexplained infertility. By taking fertilization and early embryo development outside the body and placing it under direct laboratory observation, IVF reveals aspects of the couple's fertility that standard investigation — and even IUI — cannot assess.

In an IVF cycle for an unexplained infertility couple, the embryology team directly observes the fertilization rate, the embryo developmental pattern, the blastocyst formation rate, and the morphological quality of the resulting embryos. A cycle that produces poor fertilization despite apparently adequate eggs and sperm reveals that the egg-sperm interaction is not as straightforward as the standard parameters suggested. A cycle that produces good fertilization but consistently poor embryo development points toward either egg quality or sperm quality issues at a level of detail not available from any standard assessment. A cycle that produces good blastocysts but results in failed implantation directs attention to the uterine environment — ERA, hysteroscopy, immunological assessment — that should be investigated before the next transfer.

In this way, IVF in unexplained infertility does not simply bypass the unknown cause — it actively reveals aspects of the biological problem that are invisible to every other investigation. It turns unexplained infertility into a sequence of increasingly specific clinical observations, each of which narrows the diagnostic field and directs the next step more precisely.

IVF success rates in unexplained infertility are generally comparable to those in other infertility diagnoses for the same patient's age and reserve — reflecting the fact that, in the absence of a known specific impairment to egg quality, sperm quality, or uterine function, the general IVF success rate for age and reserve applies.

Unexplained Infertility and the Importance of Not Waiting Too Long

One of the most significant clinical risks associated with unexplained infertility — beyond the diagnostic frustration — is the risk of allowing time to pass while the cause remains unidentified.

Unexplained infertility does not stay stable over time. The biological reserve — the ovarian reserve in particular — continues to decline with each passing month. A couple that receives an unexplained infertility diagnosis at 31 and spends two years attempting natural conception has a 33-year-old woman's reserve when they finally seek treatment. The time spent waiting for a natural pregnancy that does not arrive is time subtracted from the window during which treatment is most effective.

For women under 35 with unexplained infertility, a period of timed intercourse or IUI is reasonable — provided it is time-limited and followed by a clear escalation plan to IVF if pregnancy has not occurred within three to four cycles. For women over 35, the calculus shifts — time is a more precious resource, and the escalation to IVF should be earlier rather than later.

The urgency of the investigation — completing the full work-up that may reveal a specific cause — is equally time-sensitive. Completing the investigation now rather than proceeding through multiple empirical cycles first is the clinical approach that most efficiently uses the available time.

The Metro IVF Approach to Unexplained Infertility

At Metro IVF in Ambikapur, the management of unexplained infertility begins with a single clinical question: is the infertility genuinely unexplained, or is it unexplained because the investigation has not been thorough enough to find the cause?

Dr. Ashish Soni reviews every couple's previous investigation comprehensively — identifying specifically which assessments have been performed and which have not. In most couples presenting with unexplained infertility, the extended investigation — adding sperm DNA fragmentation testing, hysteroscopy, ERA in appropriate cases, endometrial biopsy, and immunological panel — reveals at least one previously unidentified contributing factor.

When the investigation is genuinely complete and no cause is found, the IVF cycle itself becomes the next diagnostic and therapeutic step — with the embryology data from the cycle informing the management of the transfer and any subsequent cycles.

In all cases, the treatment is specific, honest, and based on the best available evidence for what produces the best outcomes in couples with unexplained infertility — not a default recommendation to try IUI three times before escalating to IVF, but a genuinely individualized plan that respects the couple's age, their complete clinical picture, and the urgency of the time they cannot recover.

Your Next Step

If you have been diagnosed with unexplained infertility and want to know whether your investigation has been thorough enough to justify that label — or if you have been through empirical treatment for unexplained infertility that has not worked and are wondering what was missed — a consultation with Dr. Ashish Soni at Metro IVF in Ambikapur is the right starting point.

For many couples with unexplained infertility, the most valuable clinical service Metro IVF can provide is the investigation that changes "we cannot explain why" to "here is specifically what was found, and here is what we are going to do about it."

Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist

Unexplained infertility is often not truly unexplained — the explanation was simply not found yet. Book your consultation with Dr. Ashish Soni at Metro IVF today.